Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,390Revenue $M37.1Net Margin (%)-295.5Altman Z-Score20.2
Enterprise Value $M1,100EPS $-0.4Operating Margin %-296.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.2Pre-tax Margin (%)-295.5Higher ROA y-yN
Price/Book3.510-y EBITDA Growth Rate %-0.6Quick Ratio12.5Cash flow > EarningsY
Price/Sales34.45-y EBITDA Growth Rate %-3.8Current Ratio12.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-29.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-33.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M270ROIC % (ttm)-147.7Gross Margin Increase y-yY

Gurus Latest Trades with NVAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVAXJoel Greenblatt 2015-09-30 Buy 0.01%$6.41 - $14.14
($11.21)
$ 4.81-57%New holding110,640
NVAXFirst Eagle Investment 2014-12-31 Sold Out -0.01%$4.05 - $5.98
($5.23)
$ 4.81-8%Sold Out0
NVAXFirst Eagle Investment 2014-06-30 Add$3.69 - $5.13
($4.39)
$ 4.8110%Add 150.00%500,000
NVAXDavid Swensen 2014-03-31 Sold Out -0.23%$4.13 - $6.65
($5.59)
$ 4.81-14%Sold Out0
NVAXFirst Eagle Investment 2014-03-31 Reduce-0.01%$4.13 - $6.65
($5.59)
$ 4.81-14%Reduce -75.00%200,000
NVAXDavid Swensen 2013-12-31 Buy 0.23%$2.76 - $5.16
($3.51)
$ 4.8137%New holding25,398
NVAXGeorge Soros 2013-12-31 Sold Out -0.02%$2.76 - $5.16
($3.51)
$ 4.8137%Sold Out0
NVAXGeorge Soros 2013-09-30 Buy 0.02%$2.25 - $3.39
($2.82)
$ 4.8171%New holding573,000
NVAXFirst Eagle Investment 2013-09-30 Buy 0.01%$2.25 - $3.39
($2.82)
$ 4.8171%New holding800,000
NVAXFirst Eagle Investment 2011-03-31 Sold Out $2.15 - $2.96
($2.44)
$ 4.8197%Sold Out0
NVAXFirst Eagle Investment 2010-09-30 Add$2.01 - $2.34
($2.2)
$ 4.81119%Add 25.00%125,000
NVAXFirst Eagle Investment 2010-06-30 Reduce$2.18 - $2.97
($2.46)
$ 4.8196%Reduce -52.65%100,000
NVAXFirst Eagle Investment 2009-12-31 Buy 0.01%$2.53 - $4.41
($3.46)
$ 4.8139%New holding250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVAX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Trizzino JohnSVP, Commercial Operations 2016-01-31Buy5,855$3.6332.51view
Herrmann John A IIISVP, General Counsel 2016-01-31Buy2,072$4.389.82view
Glenn Gregory MSVP, Research and Development 2016-01-31Buy2,369$4.389.82view
PHILLIPS BARCLAY ASVP, CFO 2016-01-31Buy405$4.389.82view
Erck Stanley CCEO and President 2016-01-31Buy2,072$4.389.82view
Glenn Gregory MSVP, Research and Development 2015-12-16Sell61,886$8.58-43.94view
Herrmann John A IIISVP, General Counsel 2015-12-16Sell27,945$8.64-44.33view
EVANS GARY CDirector 2015-08-24Sell20,000$11.24-57.21view
PHILLIPS BARCLAY ASVP, CFO 2015-08-20Sell28,656$13.06-63.17view
Glenn Gregory MSVP, Research and Development 2015-08-18Sell15,000$13.52-64.42view

Quarterly/Annual Reports about NVAX:

News about NVAX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: United States Steel Corp, Tuesday Morning Corp, Novavax Inc. Feb 08 2015 
Novavax Inc. Reports Operating Results (10-Q) Nov 08 2010 
Novavax Inc. Reports Operating Results (10-Q) Aug 06 2010 
Novavax Inc. Reports Operating Results (10-Q) May 10 2010 
Novavax Inc. Reports Operating Results (10-Q) Nov 09 2009 
Novavax Inc. Reports Operating Results (10-Q) Aug 10 2009 
Novavax Inc. Reports Operating Results (10-Q) May 11 2009 

More From Other Websites
NOVAVAX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Feb 05 2016
Novavax Announces Exercise of Over-Allotment Option to Purchase Additional Shares Feb 05 2016
NOVAVAX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Jan 29 2016
Novavax Announces Closing of $300 Million Offering of Convertible Senior Notes Due 2023 - Jan 29 2016
Novavax Announces Closing of $300 Million Offering of Convertible Senior Notes Due 2023 Jan 29 2016
Novavax Prices $300 Million of Convertible Senior Notes Due 2023 - Jan 25 2016
Novavax Prices $300 Million of Convertible Senior Notes Due 2023 Jan 25 2016
NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition Jan 25 2016
[$$] Six Biotechs to Like Right Now Jan 25 2016
Technical Recap on Biotechnology Stocks -- Nektar Therapeutics, Novavax, Celgene, and Opko Health Jan 25 2016
Novavax Announces Proposed Offering of $200 Million of Convertible Senior Notes Due 2023 - Jan 25 2016
Novavax Announces Proposed Offering of $200 Million of Convertible Senior Notes Due 2023 Jan 25 2016
Jim Cramer's Top Takeaways: Dow Chemical, Novavax, Fitbit, Alcoa Jan 13 2016
Novavax Appoints Jeffrey Stoddard, M.D., Vice President, Medical Affairs - Jan 08 2016
Novavax Appoints Jeffrey Stoddard, M.D., Vice President, Medical Affairs Jan 08 2016
Novavax, Inc. breached its 50 day moving average in a Bearish Manner : January 7, 2016 Jan 07 2016
Novavax to Present at the 34th Annual J.P. Morgan Healthcare Conference - Jan 06 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK